Vor Biopharma Inc.
VOR
$0.62
-$0.0975-13.59%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/2/2025
-
TipRanks Financial Blog
3/27/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/21/2025
-
MarketBeat
3/20/2025
-
SeekingAlpha.com: All News
3/20/2025
-
Globe Newswire
3/2/2025
-
MarketBeat
3/2/2025
-
MarketBeat
2/24/2025
-
SeekingAlpha
2/13/2025
-
Globe Newswire
2/12/2025
-
GuruFocus
2/5/2025
-
MarketBeat
2/4/2025
-
MarketBeat
2/3/2025
-
Globe Newswire
1/27/2025
-
Zacks Investment Research
1/11/2025
-
MarketBeat
1/8/2025
-
Globe Newswire
1/1/2025
-
MarketBeat
12/31/2024
-
MarketBeat
12/31/2024
-
GuruFocus
12/28/2024
-
Yahoo! Finance: News
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 655 6580
Address
100 Cambridgepark Drive
Cambridge, MA 02140
Cambridge, MA 02140
Country
Year Founded
Business Description
Sector
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC)...
more
